| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |